After induction of obesity, administration of naringin showed downregulation of these lipogenic gene expressions and inhibited DAGT2 and GPAT-1 expression, which contributed to the reduction in TG synthesis and manifesting decreases in the serum and hepatic TG level. The gene discussed is GPAM; the disease is obesity due to melanocortin 4 receptor deficiency.